Please login to the form below

Not currently logged in
Email:
Password:

Roche appoints new UK general manager

Richard Erwin was previously the company's general manager for Belgium
Roche Richard Erwin

Roche has appointed Richard Erwin as its new UK general manager.

Erwin joins Roche in the UK from his role as general manager in Belgium where he spent two years, prior to which he was the company's commercial director for its western European operations.

He said: “I am excited to be returning to Roche in the UK at a time when the government has announced its vision to make the UK the global leader in life sciences.

“The UK is characterised by world leading physicians and centres. We have an NHS to be proud of but there are challenges in terms of patients with life threatening and rare diseases getting access to medicines.

“Roche is the number one investor in healthcare research and development in the world, investing a £6.2bn globally every year. We want to work closely with the UK government and the NHS to continue developing targeted medicines that meet the biggest areas of unmet need.”

Erwin joined Roche 27 years ago, initially working in sales, marketing and clinical operations before moving on to European and global leadership roles. 

Article by
Nikhil Patel

23rd October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics